NASDAQ:ACST
Acasti Pharma Stock News
$2.30
-0.0250 (-1.08%)
At Close: Dec 08, 2023
Acasti to Participate in the H.C. Wainwright Global Investment Conference
08:00am, Wednesday, 06'th Sep 2023
PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine th
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting
04:05pm, Wednesday, 09'th Aug 2023
PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company advancing GTX-104 its novel formulation of nimodipine
Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year?
11:18am, Tuesday, 28'th Feb 2023
Here is how Acasti Pharma (ACST) and Autolus Therapeutics PLC Sponsored ADR (AUTL) have performed compared to their sector so far this year.
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript
03:53pm, Tuesday, 14'th Feb 2023
Acasti Pharma Inc. (NASDAQ:ACST ) Q3 2023 Earnings Conference Call February 14, 2023 1:00 PM ET Company Representatives Jan D'Alvise - President, Chief Executive Officer Brian Ford - Chief Financial O
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31
04:15pm, Tuesday, 24'th Jan 2023
LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
09:00am, Friday, 13'th Jan 2023
LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical
LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical
Best Penny Stocks To Buy Now? 4 Stocks Under $4 To Watch
01:16pm, Wednesday, 28'th Dec 2022
Penny stocks to watch this week. The post Best Penny Stocks To Buy Now?
Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript
11:23pm, Monday, 14'th Nov 2022
Acasti Pharma Inc. (NASDAQ:ACST ) Q2 2023 Earnings Conference Call November 14, 2022 1:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Jan D'Alvise - President & CEO Brian Ford - CFO P
Acasti Pharma to Present at Q4 Investor Summit
04:15pm, Wednesday, 09'th Nov 2022
LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
04:15pm, Monday, 07'th Nov 2022
Call to be held on Monday, November 14th at 1:00 PM Eastern Time Call to be held on Monday, November 14th at 1:00 PM Eastern Time
Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference
08:15pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
LAVAL, Québec, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery ca
Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference
04:15pm, Wednesday, 14'th Sep 2022
LAVAL, Québec, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capa
Acasti Pharma to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
09:00am, Monday, 12'th Sep 2022
LAVAL, Québec, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capa
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022
08:15pm, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
Call to be held on Thursday, August 11th at 1:00 PM Eastern Time